PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2011

Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARalpha deterioration.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 21338618 ↗2011Reported benefit

Pretreatment by low-dose fibrates protects against acute free fatty acid-induced renal tubule toxicity by counteracting PPARalpha deterioration.

MouseChemical/toxinFemaleOral (in diet)0.1% clofibrate dietPretreatment (before injury)

Model: Free fatty acid-overload nephropathy (acute tubular injury)

Low-dose clofibrate pretreatment prevented acute tubular injury without metabolite accumulation via PPARalpha-dependent effects, though PPARalpha-independent toxicity persisted in null mice.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.